⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CORT News
Corcept Therapeutics Inc.
Form 8-K
sec.gov
CORT
Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call
businesswire.com
CORT
Lifshitz Law PLLC Announces Investigations of Corcept Therapeutics, Inc. (NASDAQ: CORT), Gartner, Inc. (NYSE: IT), REGENXBIO Inc. (NASDAQ: RGNX), and Graphic Packaging Holding Company (NYSE: GPK)
accessnewswire.com
CORT
IT
RGNX
GPK
Kuehn Law Encourages Investors of Corcept Therapeutics Incorporated to Contact Law Firm
prnewswire.com
CORT
Alger Russell Innovation Index Updates for Second Quarter 2026
prnewswire.com
ADBE
DOX
GNTX
KVYO
MRK
RBLX
TRMB
Z
ZS
CORT
DV
GTM
ILMN
NTAP
OKTA
P
QCOM
TDC
TWLO
ZM
Alger Russell Innovation Index Updates for Second Quarter 2026
prnewswire.com
ADBE
DOCS
DOX
GNTX
META
MRK
RBLX
TRMB
XYZ
Z
ZS
CORT
DV
GTM
ILMN
NTAP
OKTA
P
QCOM
TDC
TWLO
ZM
Kuehn Law Encourages Investors of Corcept Therapeutics Incorporated to Contact Law Firm
globenewswire.com
CORT
Form 8-K
sec.gov
CORT
Corcept Resubmits New Drug Application for Relacorilant as a Treatment for Patients with Cushing’s Syndrome
businesswire.com
CORT
Corcept Presents New Data at ADA: Improved Outcomes in Patients Receiving a GLP-1 with Difficult-to-Control Type 2 Diabetes and Hypercortisolism Treated with Korlym ®
businesswire.com
CORT